IRCT2016050227711N1已完成2 期
efficacy of Duloxetine for prevention of chemotherapy induced neuropathy in breast cancer patients
Breast Cancer Research Center of Jahad Daneshgahi0 个研究点目标入组 116 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 116
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •inclusion criteria:
- •-patient receiving paclitaxel
- •-it is the first dose of paclitaxel
- •-prior or ongoing treatment with other neurotoxic chemotherapic agents is not allowed
- •-participants with out any documented medical history of nerve compression, leptomeningeal carcinomatosis, severe depression, suicidal idea, bipolar disease, alcohol abuse, glaucoma, diabetes, thyroid abnormality, markedly abnormal renal or liver function tests
- •- not taking any medicine interfere in serotonin level
- •-not taking any analgesic medicine routinely in two weeks before entering the trial
- •exclusion criteria:
- •-sever complications with duloxetine
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Effectiveness of duloxetine for chemotherapy-induced peripheral neuropathy : a prospective study.Patient with history of cancerJPRN-UMIN000017096niversity of Tokyo Hospital20
招募中
2 期
The use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathyChemotherapy-induced peripheral neuropathyNeurological - Other neurological disordersCancer - Any cancerACTRN12617000139370Prince of Wales Hospital48
已完成
3 期
Prevention of Oxaliplatin Induced Peripheral Neuropathy (OIPN)Oxaliplatin Induced Peripheral Neuropathy (OIPN).Other anti neoplastic drugsIRCT20170211032494N2Tehran University of Medical Sciences46
进行中（未招募）
2 期
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal CancerNCT04137107Alliance for Clinical Trials in Oncology220
尚未招募
不适用
Postoperative Pain Management in laparoscopic cholecystectomy patients using DuloxetineCTRI/2021/06/034291Sharda Hospital School of Medical Sciences Research